Biolidics Receives SGX Approval to List 946 Million Share
Biolidics Amends Share Subscription Agreement With Chairman
Biolidics Ltd Amends Subscription Agreement Terms
Biolidics: Financial Statements and Related Announcement-Half Yearly Results
Insiders' S$2.18m Investments In Red Following Biolidics' S$775k Dip In Market Value
Biolidics Enters Supplemental Agreement Tied to Shenzhen Network Technology Acquisition; Biolidics Shares Plummet 10%
Biolidics Incorporates Two Subsidiaries
Biolidics to Buy Shenzhen Xiaozhao Network; Secures SG$1.5 Million Loan
Biolidics Ltd Announces Major Acquisition and Funding
Biolidics Names Ex-Weiye Executive as Financial Controller
Biolidics' CEO Steps Down; Shares Surge 10%
Biolidics Places Subsidiary Under Voluntary Liquidation
Biolidics First Quarter 2024 Earnings: S$0.001 Loss per Share (Vs S$0.001 Loss in 1Q 2023)
Bioldics' Financial Controller Steps Down
Singapore Shares Drop in Red Despite Global Rally; Biolidics Surges 20% on Wider Losses in Q1
Biolidics' Q1 Loss Widens as Revenue Slumps; Stock Surges 20%
Biolidics: Financial Statements and Related Announcement-First Quarter Results
Biolidics Flags Cybersecurity Incident; Shares Surge 10%
Biolidics Ltd Announces Executive Board Reshuffle
Biolidics Ltd Announces Major Board Restructuring
No Data
No Data